nach oben

Osteoporosis International

Erschienen in:

01.03.2015 | Original Article

Effect of ibandronate therapy on serum homocysteine and leptin in postmenopausal osteoporotic females

verfasst von: S. Tariq, S. Tariq, S. S. Alam, M. Baig

Erschienen in: Osteoporosis International | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Summary

A significant change in serum leptin level and no change in homocysteine were observed with ibandronate treatment. No correlation of homocysteine and leptin was found with bone mass density (BMD). Results indicate that ibandronate reduces serum leptin levels but how does it help in reducing the osteoporosis. It needs to be explored.

Introduction

The current study was planned to determine the effects of ibandronate on serum homocysteine and leptin levels in postmenopausal osteoporotic females and to correlate these with BMD.

Methods

Forty-two newly diagnosed and untreated postmenopausal osteoporotic females were selected on the basis of their BMD (BMD < −2.5) from Orthopaedic Out Patient Department of Shaikh Zayed Hospital, Lahore, Pakistan, and 36, age and BMI matched non-osteoporotic postmenopausal females, were also selected as a control group. Baseline physical and biochemical parameters were compared. In osteoporotic patients, changes in circulating leptin and homocysteine levels were studied after 6 months of therapy with ibandronate (150 mg). The collected data were analyzed on SPSS 16.

Results

There was no significant difference observed in the mean value of all baseline parameters except BMD in both groups. After 6 months of treatment with ibandronate (150 mg), a significant change was observed in serum leptin levels (19.48 ± 1.60 ng/ml vs. 14.09 ± 0.85 ng/ml, p < 0.002), while no considerable change observed in serum homocysteine levels (16.22 ± 0.95 μmol/l vs. 16.80 ± 1.03 μmol/l, p < 0.63). Serum leptin was found significantly correlated with anthropometric parameters. No correlation of serum leptin and homocysteine was found with BMD (r = 0.09, p value = 0.54; r = −0.17, p value = 0.27).

Conclusion

Our results show that ibandronate reduces serum leptin levels while it has no effect on serum homocysteine levels. Further studies are needed to explain how the decrease in serum leptin level may help in reducing the progression of osteoporosis.

National institutes of health consensus development panel on osteoporosis, prevention, diagnosis and therapy (2001). JAMA 285 (6):785–795

Lippuner K, Golder M, Greiner R (2005) Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int Suppl 2:S8–S17CrossRef

Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed

Baig LA, Karim SA (2006) Age at menopause, and knowledge of and attitudes to menopause, of women in Karachi, Pakistan. J Br Menopause Soc 12:71–74CrossRefPubMed

International osteoporosis foundation (2009) The Asian Audit Epidemiology, costs and burden of osteoporosis in Asia. [online] Available at: <http://www.iofbonehealth.org/publications/asian-audit-2009.html Accessed 24 April 2013

McLean RR, Jacques PF, Selhub J et al (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350(20):2042–2049CrossRefPubMed

van Meurs JBJ, Dhonukshe-Rutten RAM, Pluijm SM et al (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033–2041CrossRefPubMed

Tyagi N, Vacek TP, Fleming JT, Vacek JC, Tyagi SC (2011) Hyperhomocysteinemia decreases bone blood flow. Vasc Health Risk Manag 7:31–35PubMedCentralPubMed

LeBoff MS, Narweker R, LaCroix A et al (2009) Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 94:1207–1213CrossRefPubMedCentralPubMed

10.

Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A (2003) Relation of homocysteine, folate and vitamin B12 to bone mineral density of postmenopausal women. Bone 33:956–959CrossRefPubMed

11.

Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease. Am J Med 118:1250–1255CrossRefPubMed

12.

Ducy P, Amling M, Takeda S et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207CrossRefPubMed

13.

Karsenty G (2001) Leptin controls bone formation through a hypothalamic relay. Recent Prog Horm Res 56:401–415CrossRefPubMed

14.

Cornish J, Callon KE, Bava U et al (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405–415CrossRefPubMed

15.

Chan JL, Mantzoros CS (2005) Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 366:74–85CrossRefPubMed

16.

Hamrick MW, Pennington C, Newton D, Xie D, Isales C (2004) Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34:376–383CrossRefPubMed

17.

Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL (1999) Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630–1638PubMed

18.

Holloway WR, Collier FM, Aitken CJ et al (2002) Leptin inhibits osteoclast generation. J Bone Miner Res 17:200–209CrossRefPubMed

19.

Scotece M, Conde J, Vuolteenaho K et al (2014) Adipokines as drug targets in joint and bone disease. Drug Discov Today 19:241–258CrossRefPubMed

20.

Brusin JH, Clung MC (2009) Update on bone densitometry. Radiol technol 81:153BD–170BDPubMed

21.

Miller PD, McCalung MR, Stakkestad JA, Luckey M, Reginster JY, Reckor RR et al (2005) Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Mineral Res 20(8):1315–1322CrossRef

22.

Cakmak A, Posaci C, Dogan E, Caliskan S, Guclu S, Altunyurt S (2005) Raloxifene increases serum leptin levels in postmenopausal women: a prospective study. Am J Obstet Gynecol 193:347–351CrossRefPubMed

23.

Lambrinoudaki IV, Christodoulakos GE, Economou EV et al (2008) Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Maturitas 59:62–71CrossRefPubMed

24.

Lavoie H, Taylor A, Sharpless J, Anderson E, Strauss C, Hall J (1999) Effects of short-term hormone replacement on serum leptin levels in postmenopausal women. Clin Endocrinol 51(4):415–422CrossRef

25.

Elbers JM, de RooGW P-SC et al (1999) Effect of administration of 17 beta-oestradiol on serum leptin levels in healthy postmenopausal women. Clin Endocrinol 51:449–454CrossRef

26.

Sebastian-Ochoa AS, Fernandez-Garcıa DF, Reyes-Garcıa R et al (2012) Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate. Menopause 19(2):172–177CrossRefPubMed

27.

Kocyigit H, Bal S, Atay A, Koseoglu M, Gurgan A (2013) Plasma leptin values in postmenopausal women with osteoporosis. Bosn J Basic Med Sci 13:192–196PubMed

28.

Shaarawy M, Abassi AF, Hassan H, Salem ME (2003) Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. Fertil Steril 79:919–924CrossRefPubMed

29.

Bonte DC, Ilie AC, Iacob RE et al (2013) The evaluation of the leptin implication in postmenopausal osteoporosis. J Food Agricult Environ 11(1):244–245

30.

Pasco JA, Henry MJ, Kotowitz MA et al (2001) Serum leptin levels are associated with bone mass in non-obese women. J Clin Endocrinol Metab 86(5):1884–1887PubMed

31.

Bart R, Frisch B, von Tresckow E, Bart C (2007) (2007) Bisphosphonates in medical practice: Actions, side effects, and indications. Springer Publishing, USACrossRef

32.

Amling M, Takeda S, Karsenty GA (2000) Neuro (endo) crine regulation of bone remodeling. Bioessays 22:970–975CrossRefPubMed

33.

Troyanov S, Hebert MJ, Masse M, Vigneault N, Sirois I, Madore F (2003) Soluble Fas: a novel predictor of atherosclerosis in dialysis patients. Am J Kidney Dis 41:1043–1051CrossRefPubMed

34.

Icin T, Kovacev-Zavisic B, Medic-Stojanoska M et al (2009) Bone resorption and antiresorptive effect of bisphosphonates related to homocysteinaemia. 11th European Congress of Endocrinology, organized by the European society of endocrinology, Istanbul, pp 25–29

35.

Saito M, Fujii K, Marumo K (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 79:160–168CrossRefPubMed

36.

Perier MA, Gineyts E, Munoz F, Sornay-Rendu E, Delmas PD (2007) Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int 18:1329–1336CrossRefPubMed

37.

McLean RR, Hannan MT (2007) B vitamins, homocysteine, and bone disease: Epidemiology and pathophysiology. Curr Osteoporos Rep 5:112–119CrossRefPubMed

38.

Enneman AW, Swart MKA, Zillikens MC et al (2014) The association between plasma homocysteine levels and bone quality and bone mineral density parameters in older persons. Bone 63:141–146CrossRefPubMed

39.

Lateef M, Baig M, Azhar A (2010) Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females. Osteoporos Int 21:751–755CrossRefPubMed

40.

Ibrahim SE, ElShishtawy HF, Helmy A, Galal ZA, Abdel Salam MH (2011) Serum leptin concentration, bone mineral density and bone biochemical markers in a sample of Egyptian women: a possible relationship. The Egyptian Rheumatologist 33(4):171–177CrossRef

41.

Zhao LJ, Jiang H, Papasian CJ et al (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Min Res 23(1):17–29CrossRef

Titel: Effect of ibandronate therapy on serum homocysteine and leptin in postmenopausal osteoporotic females
verfasst von: S. Tariq
S. Tariq
S. S. Alam
M. Baig
Publikationsdatum: 01.03.2015
Verlag: Springer London
Erschienen in: Osteoporosis International / Ausgabe 3/2015
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-014-2909-9

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Summary

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Association between dietary fat intake and bone mineral density in Korean adults: data from Korea National Health and Nutrition Examination Survey IV (2008∼2009)

Mediating effects on health-related quality of life in adults with osteoporosis: a structural equation modeling

Trends in fall-related hospitalisations in older people living in aged care facilities

Length of sick leave as a risk marker of hip fracture: a nationwide cohort study from Sweden

Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials